Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | JAK2 |
| Variant | I540_E543delinsMK |
| Impact List | indel |
| Protein Effect | unknown |
| Gene Variant Descriptions | JAK2 I540_E543delinsMK results in a deletion of four amino acids of the Jak2 protein from amino acids 540 to 543, combined with the insertion of a methionine (M) and a lysine (K) at the same site (UniProt.org). I540_E543delinsMK has been identified in sequencing studies (PMID: 22642932, PMID: 17984312, PMID: 17914411), but has not been biochemically characterized and therefore, its effect on Jak2 protein function is unknown (PubMed, Jun 2025). |
| Associated Drug Resistance | |
| Category Variants Paths |
JAK2 mutant JAK2 exon12 JAK2 I540_E543delinsMK |
| Transcript | NM_004972.4 |
| gDNA | chr9:g.5070029_5070040delinsATGAAG |
| cDNA | c.1618_1629delinsATGAAG |
| Protein | p.I540_E543delinsMK |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_001322194.2 | chr9:g.5070029_5070040delinsATGAAG | c.1618_1629delinsATGAAG | p.I540_E543delinsMK | RefSeq | GRCh38/hg38 |
| NM_004972.4 | chr9:g.5070029_5070040delinsATGAAG | c.1618_1629delinsATGAAG | p.I540_E543delinsMK | RefSeq | GRCh38/hg38 |
| NM_001322194 | chr9:g.5070029_5070040delinsATGAAG | c.1618_1629delinsATGAAG | p.I540_E543delinsMK | RefSeq | GRCh38/hg38 |
| NM_001322196 | chr9:g.5070029_5070040delinsATGAAG | c.1618_1629delinsATGAAG | p.I540_E543delinsMK | RefSeq | GRCh38/hg38 |
| NM_001322195.1 | chr9:g.5070029_5070040delinsATGAAG | c.1618_1629delinsATGAAG | p.I540_E543delinsMK | RefSeq | GRCh38/hg38 |
| NM_001322196.1 | chr9:g.5070029_5070040delinsATGAAG | c.1618_1629delinsATGAAG | p.I540_E543delinsMK | RefSeq | GRCh38/hg38 |
| NM_001322196.2 | chr9:g.5070029_5070040delinsATGAAG | c.1618_1629delinsATGAAG | p.I540_E543delinsMK | RefSeq | GRCh38/hg38 |
| NM_001322195 | chr9:g.5070029_5070040delinsATGAAG | c.1618_1629delinsATGAAG | p.I540_E543delinsMK | RefSeq | GRCh38/hg38 |
| NM_001322194.1 | chr9:g.5070029_5070040delinsATGAAG | c.1618_1629delinsATGAAG | p.I540_E543delinsMK | RefSeq | GRCh38/hg38 |
| NM_001322195.2 | chr9:g.5070029_5070040delinsATGAAG | c.1618_1629delinsATGAAG | p.I540_E543delinsMK | RefSeq | GRCh38/hg38 |
| NM_004972 | chr9:g.5070029_5070040delinsATGAAG | c.1618_1629delinsATGAAG | p.I540_E543delinsMK | RefSeq | GRCh38/hg38 |
| NM_004972.3 | chr9:g.5070029_5070040delinsATGAAG | c.1618_1629delinsATGAAG | p.I540_E543delinsMK | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|